CAR-T Therapy trials for Systemic Lupus Erythematosus, SLE

All CAR-T Therapy trials · All Systemic Lupus Erythematosus, SLE trials

Phase breakdown

Recruiting trials studying CAR-T Therapy for Systemic Lupus Erythematosus, SLE

• A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
  NCT07339332 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
  NCT06822881 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
  NCT07031713 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study CAR-T Therapy for Systemic Lupus Erythematosus, SLE?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.